New probe aims to stop post-polypectomy bleeding in high-risk patients
NCT ID NCT02875353
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a special probe that checks blood flow in ulcers left after colon polyp removal. The goal is to see if using this probe to guide treatment can prevent delayed bleeding, especially in patients taking blood thinners or with large polyps. About 180 high-risk adults will be randomly assigned to either standard care or probe-guided care, and bleeding rates will be compared over 30 days.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Doppler endoscopic probe (a device that detects blood flow)
- What this could lead to
- If successful, this device could become a standard tool to prevent dangerous delayed bleeding after colon polyp removal, especially for patients on blood thinners.
- What could go wrong
- This is a relatively small, early-stage trial (180 participants) and the device may not reduce bleeding rates significantly compared to standard care. The procedure also carries its own minor risks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BENIGN COLON POLYPS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kaiser Permanente-Downey Medical Center
Downey, California, 90242, United States
-
University of California, Los Angeles, Ronald Reagan Medical Center
Los Angeles, California, 90095, United States
-
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
West Los Angeles, California, 90073-1003, United States